AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE

28 registrations across 3 African markets— 28 active

Markets with ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
KAVIDEZA DISTAB TABLETS (Each dispersible tablet contains Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)🇬🇭GhanaactiveDec 2030
FDA/SD.255-111995🇬🇭GhanaactiveDec 2030
FDA/SD.255-111995🇬🇭GhanaactiveDec 2030
KAVIDEZA DISTAB TABLETS (Each dispersible tablet contains Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)🇬🇭GhanaactiveDec 2030
ABLADO DT TABLETS🇬🇭GhanaactiveAug 2030
ABLADO TABLETS🇬🇭GhanaactiveAug 2030
ABLADO TABLETS🇬🇭GhanaactiveAug 2030
ABLADO DT TABLETS🇬🇭GhanaactiveAug 2030
ABACAVIR_DOLUTEGRAVIR_LAMIVUDINE​ ​TABLETS🇬🇭GhanaactiveJul 2030
ABACAVIR_DOLUTEGRAVIR_LAMIVUDINE​ ​TABLETS🇬🇭GhanaactiveJul 2030
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE ​TABLETS🇬🇭GhanaactiveDec 2028
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE ​TABLETS🇬🇭GhanaactiveDec 2028
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TABLETS FOR ORAL SUSPENSION (Each tablet contains: Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)🇬🇭GhanaactiveFeb 2027
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TABLETS FOR ORAL SUSPENSION (Each tablet contains: Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 60mg/5mg/30mg)🇬🇭GhanaactiveFeb 2027
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Film-coated 600mg/50mg/300mg
Tablet, Film-coated
🌍WWAurobindo Pharma Ltdactive
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaM/S HETERO LABS LIMITEDactive
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Dispersible 60mg/5mg/30mg
Tablet, Dispersible
🌍WWMicro Labs Limitedactive
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Dispersible 60 mg/5 mg/30 mg
Tablet, Dispersible
🌍WWCipla Ltdactive
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Dispersible 60mg/5mg/30mg
Tablet, Dispersible
🌍WWLupin Ltdactive
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Dispersible 60mg/5mg/30mg
Tablet, Dispersible
🌍WWAurobindo Pharma Ltdactive
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaM/S HETERO LABS LIMITEDactive
Abacavir (sulfate)/Dolutegravir (sodium)/Lamivudine Tablet, Film-coated 60mg/5mg/30mg
Tablet, Film-coated
🌍WWMylan Laboratories Ltd.active
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaLAURUS LABS LIMITED -active
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaM/S HETERO LABS LIMITEDactive
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaM/S HETERO LABS LIMITEDactive

ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE in Africa — Regulatory Overview

ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE is registered across 3 African markets with 28 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, WW. AfricaRegulatory refreshes this data daily from official government sources.

Of the 28 registrations, 28 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.